Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the early prostate cancer program

William A See; Manfred P Wirth; David G McLeod; Peter Iversen; Ira Klimberg; Donald Gleason; Gerald Chodak; James Montie; Chris Tyrrell; D M A Wallace; Karl P J Delaere; Sigmund Vaage; Teuvo L J Tammela; Olavi Lukkarinen; Bo-Eric Persson; Kevin Carroll; Geert J C M Kolvenbag; Casodex Early Prostate Cancer Trialist Group

Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the early prostate cancer program

William A See, Manfred P Wirth, David G McLeod, Peter Iversen, Ira Klimberg, Donald Gleason, Gerald Chodak, James Montie, Chris Tyrrell, D M A Wallace, Karl P J Delaere, Sigmund Vaage, Teuvo L J Tammela, Olavi Lukkarinen, Bo-Eric Persson, Kevin Carroll, Geert J C M Kolvenbag, Casodex Early Prostate Cancer Trialist Group

Mave-, Tarm- og Leversygdomme

212 Citationer (Scopus)

Abstract

We determine the efficacy and tolerability of bicalutamide as immediate therapy, either alone or as adjuvant to treatment of curative intent, in patients with clinically localized or locally advanced prostate cancer.

Originalsprog	Engelsk
Tidsskrift	Journal of Urology
Vol/bind	168
Udgave nummer	2
Sider (fra-til)	429-35
Antal sider	7
ISSN	0022-5347
Status	Udgivet - 1 aug. 2002

Citationsformater

See, W. A., Wirth, M. P., McLeod, D. G., Iversen, P., Klimberg, I., Gleason, D., Chodak, G., Montie, J., Tyrrell, C., Wallace, D. M. A., Delaere, K. P. J., Vaage, S., Tammela, T. L. J., Lukkarinen, O., Persson, B.-E., Carroll, K., Kolvenbag, G. J. C. M., & Casodex Early Prostate Cancer Trialist Group (2002). Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the early prostate cancer program. Journal of Urology, 168(2), 429-35.

Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the early prostate cancer program. / See, William A; Wirth, Manfred P; McLeod, David G et al.
I: Journal of Urology, Bind 168, Nr. 2, 01.08.2002, s. 429-35.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning

See, WA, Wirth, MP, McLeod, DG, Iversen, P, Klimberg, I, Gleason, D, Chodak, G, Montie, J, Tyrrell, C, Wallace, DMA, Delaere, KPJ, Vaage, S, Tammela, TLJ, Lukkarinen, O, Persson, B-E, Carroll, K, Kolvenbag, GJCM & Casodex Early Prostate Cancer Trialist Group 2002, 'Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the early prostate cancer program', Journal of Urology, bind 168, nr. 2, s. 429-35.

@article{f2893a2f35e64e719f29b5a43f12d433,

title = "Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the early prostate cancer program",

abstract = "We determine the efficacy and tolerability of bicalutamide as immediate therapy, either alone or as adjuvant to treatment of curative intent, in patients with clinically localized or locally advanced prostate cancer.",

author = "See, {William A} and Wirth, {Manfred P} and McLeod, {David G} and Peter Iversen and Ira Klimberg and Donald Gleason and Gerald Chodak and James Montie and Chris Tyrrell and Wallace, {D M A} and Delaere, {Karl P J} and Sigmund Vaage and Tammela, {Teuvo L J} and Olavi Lukkarinen and Bo-Eric Persson and Kevin Carroll and Kolvenbag, {Geert J C M} and {Casodex Early Prostate Cancer Trialist Group}",

year = "2002",

month = aug,

day = "1",

language = "English",

volume = "168",

pages = "429--35",

journal = "Journal of Urology",

issn = "0022-5347",

publisher = "Elsevier Inc",

number = "2",

}

TY - JOUR

T1 - Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the early prostate cancer program

AU - See, William A

AU - Wirth, Manfred P

AU - McLeod, David G

AU - Iversen, Peter

AU - Klimberg, Ira

AU - Gleason, Donald

AU - Chodak, Gerald

AU - Montie, James

AU - Tyrrell, Chris

AU - Wallace, D M A

AU - Delaere, Karl P J

AU - Vaage, Sigmund

AU - Tammela, Teuvo L J

AU - Lukkarinen, Olavi

AU - Persson, Bo-Eric

AU - Carroll, Kevin

AU - Kolvenbag, Geert J C M

AU - Casodex Early Prostate Cancer Trialist Group

PY - 2002/8/1

Y1 - 2002/8/1

N2 - We determine the efficacy and tolerability of bicalutamide as immediate therapy, either alone or as adjuvant to treatment of curative intent, in patients with clinically localized or locally advanced prostate cancer.

AB - We determine the efficacy and tolerability of bicalutamide as immediate therapy, either alone or as adjuvant to treatment of curative intent, in patients with clinically localized or locally advanced prostate cancer.

M3 - Journal article

C2 - 12131282

SN - 0022-5347

VL - 168

SP - 429

EP - 435

JO - Journal of Urology

JF - Journal of Urology

IS - 2

ER -

Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the early prostate cancer program

Abstract

Fingeraftryk

Citationsformater